LGHTvsFBTETF Comparison
Langar Global HealthTech ETF (LGHT) belongs to the Healthcare Technology segment. First Trust NYSE Arca Biotechnology Index Fund ETF (FBT) is part of the US Health Care segment. Both ETFs have the same top 1 sector exposures: Healthcare. LGHT is more expensive with a Total Expense Ratio (TER) of 0.85%, versus 0.54% for FBT. LGHT is up 2.64% year-to-date (YTD) with -$1M in YTD flows. FBT performs better with 32.78% YTD performance, and +$964M in YTD flows. Run a side-by-side ETF comparison of LGHT and FBT below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
LGHT vs FBT performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | LGHT FBT | +15.56%+11.39% | +28.19%+27.27% | +2.64%+32.78% | +1.02%+55.96% | n/a+79.36% | n/a+56.41% |
| Flows | LGHT FBT | -+$13M | -$522K-$159M | -$1M+$964M | -$941K+$1.04B | -+$618M | -+$274M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | LGHT FBT | +37.84%+23.11% | +25.46%+22.01% | n/a+21.07% | n/a+22.19% |
| Max drawdown | LGHT FBT | -10.33%-4.37% | -25.58%-14.27% | n/a-19.92% | n/a-29.91% |
| Max drawdown duration | LGHT FBT | 32d30d | 310d126d | n/a237d | n/a1159d |
LGHT | FBT | |
Last sale 9/3/2026 at 1:30 PM | $273.79 | |
| Previous close 09/02/2026 | $273.47 | |
| Consolidated volume 09/02/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
LGHT | FBT | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
LGHT | FBT | |
|---|---|---|
| Last price | – | $273.79 |
| 1D performance | – | +0.12% |
| AuM | $2.36 M | $2.98 B |
| E/R | 0.85% | 0.54% |
LGHT | FBT | |
|---|---|---|
| Management strategy | Active | Passive |
| Provider | Langar Investment Management | First Trust |
| Benchmark | - | NYSE Arca Biotechnology Index |
| N° of holdings | 30 | 30 |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | January 10, 2024 | June 19, 2006 |
| ESG | Yes | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
